IGHE and asthma: Asthma is a common disease with a clinical severity that ranges from mild forms controlled with β2-agonists alone or low doses of ICSs to very severe forms requiring high doses of ICSs and oral corticosteroids and, increasingly, biologics, such as the anti-IgE mAb omalizumab.29